The biomedical model of mental disorder: a critical analysis of its validity, utility, and effects on psychotherapy research, Clin Psychol Rev, vol.33, issue.7, pp.846-61, 2013. ,
Psychiatric emergencies (part III): psychiatric symptoms resulting from organic diseases, Eur Rev Med Pharmacol Sci, vol.17, issue.1, p.23436670, 2013. ,
Psychiatric manifestations of systemic illness, Emerg Med Clin North Am, vol.18, issue.2, p.10767878, 2000. ,
Physical illness presenting as psychiatric disease. Arch Gen Psychiatry, vol.35, p.568461, 1978. ,
The occurrence of organic disease of possible or probable aetiological significance in a population of 268 cases of first episode schizophrenia, Psychol Med, vol.17, issue.2, pp.371-380, 1987. ,
Unrecognized medical emergencies admitted to psychiatric units, Am J Emerg Med, vol.18, issue.4, p.10919525, 2000. ,
, Haute Autorité de Santé -Guide -Affection Longue Durée -Affections psychiatriques de longue durée Troubles dépressifs récurrents ou persistants de l'adulte. Février, 2009.
, Recommandation de bonne pratique en psychiatrie : Comment améliorer la prise en charge somatique des patients ayant une pathologie psychiatrique sévère et chronique, Recommandations Juin, 2015.
Treatment-resistant depression: definition and treatment approaches, Review. PubMed PMID, vol.51, p.2112132, 1990. ,
Is asymptomatic hyponatremia really asymptomatic?, Am J Med, vol.119, issue.7, pp.79-82, 2006. ,
What does plasma CRP tell us about peripheral and central inflammation in depression? Mol Psychiatry, 2018. ,
Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity, J Epidemiol Community Health, vol.61, issue.7, p.17568057, 2007. ,
Association between Serum Vitamin Levels and Depression in U.S. Adults 20 Years or Older Based on National Health and Nutrition Examination Survey, Int J Environ Res Public Health, vol.15, issue.6, 2009. ,
Vitamin B12 deficiency: an important reversible comorbidity in neuropsychiatric manifestations, Indian J Psychol Med, vol.37, issue.1, pp.26-35, 2015. ,
, Neuropsychiatrie : Tendances et Débats, vol.32, pp.9-18, 2008.
Antidepressant-Resistant Depression in Patients With Comorbid Subclinical Hypothyroidism or High-Normal TSH Levels, Am J Psychiatry, vol.175, issue.7, pp.598-604, 2018. ,
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, World J Biol Psychiatry, vol.19, issue.3, pp.162-174, 2017. ,
Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation -recommendations from the French National Network of Pharmacogenetics, Therapie ,
, , vol.72, pp.311-318
Membrane lipidomics in schizophrenia patients: a correlational study with clinical and cognitive manifestations, Transl Psychiatry, vol.6, issue.10, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01380206
Mitochondrial dysfunction in psychiatric and neurological diseases: cause(s), consequence(s), and implications of antioxidant therapy, Biofactors, vol.39, issue.4, pp.392-406, 2013. ,
A causality algorithm to guide diagnosis and treatment of catatonia due to autoimmune conditions in children and adolescents, Schizophr Res, issue.17, pp.30375-30379, 2017. ,
Diagnostic and treatment implications of psychosis secondary to treatable metabolic disorders in adults: a systematic review, Orphanet J Rare Dis, vol.9, p.65, 2014. ,
Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis, Acta Psychiatr Scand, 2018. ,
Management of HSV encephalitis in adults and neonates: diagnosis, prognosis and treatment, Herpes, vol.14, issue.1, 2007. ,
The importance of not jumping to conclusions: syphilis as an organic cause of neurological, psychiatric and endocrine presentations, BMJ Case Rep, p.2014207900, 2015. ,
Psychotic mania as the solitary manifestation of neurosyphilis ,
, , vol.17, p.24, 2018.
New-onset delusions and hallucinations in patients infected with HIV, J Psychiatry Neurosci, vol.26, issue.3, p.11394192, 2001. ,
Psychiatric manifestations of Lyme borreliosis, J Clin Psychiatry, vol.54, issue.7, p.8335653, 1993. ,
Whipple limbic encephalitis, Arch Neurol, vol.68, issue.11, pp.1471-1474, 2011. ,
Recommended diagnostic criteria for paraneoplastic neurological syndromes, JNNP, vol.75, pp.1135-1175, 2004. ,
Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium, Clin Infect Dis, vol.57, pp.1114-1142, 2013. ,
,
, Rev Med Interne, vol.33, issue.9, pp.503-516, 2009.
Hashimoto encephalopathy: literature review, Acta Neurol Scand, vol.135, issue.3, pp.285-290, 2016. ,
The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review, Mult Scler, vol.21, issue.3, pp.305-322, 2015. ,
A Case of Mast Cell Leukemia: A Review of the Pathophysiology of Systemic Mastocytosis and Associated Psychiatric Symptoms, Psychosomatics, issue.18, pp.30129-30133, 2018. ,
Neuropsychiatric symptoms in Alzheimer's disease. Alzheimers Dement, vol.7, pp.532-541, 2011. ,
Psychiatric complications in Parkinson disease, Am J Geriatr Psychiatry, vol.13, issue.10, pp.844-51, 2005. ,
Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies, Am J Psychiatry, vol.161, issue.5, pp.843-852, 2004. ,
Identifying Specific Clinical Symptoms of Behavioral Variant Frontotemporal Dementia Versus Differential Psychiatric Disorders in Patients Presenting With a Late-Onset Frontal Lobe Syndrome, J Clin Psychiatry, vol.77, issue.10, pp.1391-1395, 2016. ,
Frontal Lobe Epilepsy: A Primer for Psychiatrists and a Systematic Review of Psychiatric Manifestations, Psychosomatics, vol.57, issue.5, pp.445-64, 2016. ,
Psychiatric comorbidities in temporal lobe epilepsy: possible relationships between psychotic disorders and involvement of limbic circuits, Rev Bras Psiquiatr, 2012. ,
, , vol.5, pp.273-85, 2015.
The neuropsychiatric profile of Addison's disease: revisiting a forgotten phenomenon, J Neuropsychiatry Clin Neurosci, vol.18, issue.4, pp.450-459, 2006. ,
Unusual presentation of pheochromocytoma: thirteen years of anxiety requiring psychiatric treatment. Endocrinol Diabetes Metab Case Rep, pp.17-0176, 2018. ,
Clinical recognition and aspects of the cerebral folate deficiency syndromes, Clin Chem Lab Med, vol.51, issue.3, pp.497-511, 2013. ,
The basis for folinic acid treatment in neuro-psychiatric disorders, Biochimie, vol.126, pp.79-90, 2016. ,
Mixed neuropsychiatric clinical manifestations associated with vitamin B12 deficiency, Asian J Psychiatr, vol.36, pp.25-27, 2018. ,
,
, , vol.42, pp.208-221, 2016.
Psychiatric manifestations in cerebrotendinous xanthomatosis. Transl Psychiatry, vol.3, p.302, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01595966
Cognitive and psychiatric symptoms in Wilson disease, Handb Clin Neurol, vol.142, pp.121-140, 2017. ,
Hemochromatosis-induced bipolar disorder: a case report, Gen Hosp Psychiatry, 2012. ,
, , vol.34, pp.101-102
, Psychiatric Aspects of Acute Porphyria: a Comprehensive Review Current Psychiatry Reports, vol.20, p.5, 2018.
Neuropsychiatric aspects of the adult variant of Tay-Sachs disease, J Neuropsychiatry Clin Neurosci, vol.10, issue.1, pp.10-19, 1998. ,
,
The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation, J Inherit Metab Dis, vol.38, issue.6, pp.1155-1161, 2015. ,
Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency, 2004. ,
, , 2017.
Adolescence/adult onset MTHFR deficiency may manifest as isolated and treatable distinct neuro-psychiatric syndromes, Orphanet Journal of Rare Diseases, vol.13, p.29, 2018. ,
Systematic Review and Meta-Analysis of Neuropsychiatric Symptoms and Executive Functioning in Adults With Phenylketonuria, Dev Neuropsychol, vol.41, issue.4, pp.245-260, 2016. ,
General Features of Complex Systems" (PDF), 2002. ,
How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors, Am J Psychiatry, vol.158, issue.6, pp.848-56, 2001. ,
, Caisse Nationale d'Assurance Maladie -Améliorer la qualité du système de santé et maîtriser les dépenses -Rapport au ministre chargé de la Sécurité sociale et au Parlement sur l'évolution des charges et produits de l'Assurance Maladie au titre de 2019